By examining the latest research findings and discussing the clinical implications, this paper aims to contribute to a better understanding of FLT3 mutations in AML and provide insights that may guide future research directions and facilitate the development of more effective therapeutic strategies. The gene discussed is FLT3; the disease is acute myeloid leukemia.